文献速递心血管CTMR

非缺血性心肌病中基于心脏双能CT对比增强虚拟平扫血衰减推导的合成细胞外容积分数

Synthetic Extracellular Volume Fraction Derived Using Virtual Unenhanced Attenuation of Blood on Contrast-Enhanced Cardiac Dual-Energy CT in Nonischemic Cardiomyopathy.
PubMed 文献 · AJR Am J Roentgenol · 2021-10-13

本研究在51例非缺血性心肌病患者中,比较了利用虚拟平扫血衰减推导的合成血细胞比容计算的合成ECV与常规血清血细胞比容计算的ECV,两者均来自对比增强心脏双能CT,并以心脏MRI的ECV为参考标准。结果显示合成ECV与常规ECV一致性极好(CCC=0.95),且与MRI-ECV的偏差均较小。

要点

  • 合成ECV与常规ECV一致性极好(CCC=0.95)。
  • 合成ECV与MRI-ECV偏差-0.78%(95%LOA -5.25%至3.69%)。
  • 虚拟平扫血衰减可推导合成血细胞比容,免去抽血。

核心结论

  • 来自双能CT的合成ECV与常规ECV一致性极好,且与心脏MRI衍生的ECV关联相当。

研究设计与样本

  • 回顾性研究,主要样本51例非缺血性心肌病患者(26男25女,平均年龄59.9±15.6岁),均行平衡期对比增强心脏双能CT和心脏MRI并在两项检查6小时内测血清血细胞比容;另取198例同日因疑似肺栓塞行胸部双能CT并有血清血细胞比容的患者,通过线性回归建立合成血细胞比容公式。

诊断标准与关键数值

  • 合成血细胞比容公式为:合成血细胞比容 = 0.85 ×(血虚拟平扫衰减)- 5.40;常规ECV与合成ECV的CCC为0.95;MRI-ECV与常规ECV偏差-0.44%(95%一致性界限 -5.10%至4.22%);MRI-ECV与合成ECV偏差-0.78%(95%一致性界限 -5.25%至3.69%)。

临床应用与阅片要点

  • 利用虚拟平扫血衰减推导合成血细胞比容,可在不抽血的情况下于双能CT上计算合成ECV,用于心肌组织表征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Current methods for calculating the myocardial extracellular volume (ECV) fraction require blood sampling to determine the serum hematocrit. Synthetic hematocrit and thus synthetic ECV may be derived using unenhanced attenuation of blood. By use of virtual unenhanced (VUE) attenuation of blood, contrast-enhanced dual-energy CT (DECT) may allow synthetic ECV calculations without unenhanced acquisition. OBJECTIVE. The purpose of this study was to compare synthetic ECV calculated using synthetic hematocrit derived from VUE images and conventional ECV calculated using serum hematocrit, both of which were obtained by contrast-enhanced DECT, with ECV derived from MRI used as the reference standard. METHODS. This retrospective study included 51 patients (26 men and 25 women; mean age, 59.9 ± 15.6 [SD] years) with nonischemic cardiomyopathy who, as part of an earlier prospective investigation, underwent equilibrium phase contrast-enhanced cardiac DECT and cardiac MRI and had serum hematocrit measured within 6 hours of both tests. A separate retrospective sample of 198 patients who underwent contrast-enhanced thoracic DECT performed on the same day for suspected pulmonary embolism and serum hematocrit measurement was identified to derive a synthetic hematocrit formula using VUE attenuation of blood by linear regression analysis. In the primary sample, two radiologists independently used DECT iodine maps to obtain the conventional ECV using serum hematocrit and the synthetic ECV using synthetic hematocrit based on the independently derived formula. The concordance correlation coefficient (CCC) was computed between conventional ECV and synthetic ECV from DECT. Conventional ECV and synthetic ECV from DECT were compared with the ECV derived from MRI in Bland-Altman analyses. RESULTS. In the independent sample, the linear regression formula for synthetic hematocrit was as follows: synthetic hematocrit = 0.85 × (VUE attenuation of blood) - 5.40. In the primary sample, the conventional ECV and synthetic ECV from DECT showed excellent agreement (CCC, 0.95). Bland-Altman analysis showed a small bias of -0.44% (95% limits of agreement, -5.10% to 4.22%) between MRI-derived ECV and conventional ECV from DECT as well as a small bias of -0.78% (95% limits of agreement, -5.25% to 3.69%) between MRI-derived ECV and synthetic ECV from DECT. CONCLUSION. Synthetic ECV and conventional ECV derived from DECT show excel lent agreement and a comparable association with ECV derived from cardiac MRI. CLINICAL IMPACT. Synthetic hematocrit from VUE attenuation of blood may allow myocardial tissue characterization on DECT without the inconvenience of blood sampling.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Kim NY, Im DJ, Youn JC, et al. Synthetic Extracellular Volume Fraction Derived Using Virtual Unenhanced Attenuation of Blood on Contrast-Enhanced Cardiac Dual-Energy CT in Nonischemic Cardiomyopathy. AJR Am J Roentgenol. 2021. PMID: 34643105. doi:10.2214/AJR.21.26654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。